http://orcid.org/0000-0002-9292-1477
References
- Hegedüs L. Clinical practice. The thyroid nodule. N Engl J Med. 2004;351(17):1764–1771.
- Singer PA, Cooper DS, Daniels GH, et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med. 1996;156(19):2165–2172.
- Haraj NE, Ahandar H, El Aziz S, et al. [Association of hyperthyroidism with differentiated thyroid cancer]. Pan Afr Med J. 2016;24:18.
- Salih AM, Kakamad FH, Nihad H. Hyperfunctioning papillary thyroid carcinoma: a case report with literature review. Int J Surg Case Rep. 2016;26:202–204.
- Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
- Mirfakhraee S, Mathews D, Peng L, et al. A solitary hyperfunctioning thyroid nodule harboring thyroid carcinoma: review of the literature. Thyroid Res. 2013;6(1):7.
- Harach HR, Sánchez SS, Williams ED. Pathology of the autonomously functioning (hot) thyroid nodule. Ann Diagn Pathol. 2002;6(1):10–19.
- De Rosa G, Testa A, Maurizi M, et al. Thyroid carcinoma mimicking a toxic adenoma. Eur J Nucl Med. 1990;17(3–4):179–184.
- Girelli ME, Casara D, Rubello D, et al. Severe hyperthyroidism due to metastatic papillary thyroid carcinoma with favorable outcome. J Endocrinol Invest. 1990;13(4):333–337.
- Manmadharao V, Kirankumar G, Jayaramudu YV, et al. A rare case of papillary carcinoma of thyroid with hyperthyroidism. J Evol Med Dent Sci. 2015;4(10):1694–1698.
- Gabriele R, Letizia C, Borghese M, et al. Thyroid cancer in patients with hyperthyroidism. Horm Res. 2003;60(2):79–83.
- Kinkel B, Bucerius J, Risse JH. [Graves’ disease and papillary thyroid cancer – coincidence or association?]. Dtsch Med Wochenschr. 2007;132(18):983–986.
- Niepomniszcze H, Suárez H, Pitoia F, et al. Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620I) and a mutation of the Ki-RAS (G12C) genes. Thyroid. 2006;16(5):497–503.
- Gozu H, Avsar M, Bircan R, et al. Does a Leu 512 Arg thyrotropin receptor mutation cause an autonomously functioning papillary carcinoma? Thyroid. 2004;14(11):975–980.